Plantible | $30,000,000 | (Nov 19, 2024)
IonKraft | $3,706,797 | (Nov 19, 2024)
Bluespine | $7,200,000 | (Nov 19, 2024)
Cadence
United States
- Los Angeles, California
- 14/12/2021
- Series B
- $100,000,000
Cadence is a pioneering health technology company helping national health systems deliver world-class care outside of the four walls of the hospital. Our Care in Sync™ platform couples powerful new technology with clinical excellence, providing patients with a precise and personal level of care through remote patient monitoring.
At Cadence, we aim to exceed the expectations of our patients, clinicians, and partners every day. Our team values trust and autonomy, and we empower one another to make decisions, solve problems and build something better. We give clear, candid feedback with the utmost honesty and encouragement.
We're currently looking for people to join our Care Delivery, Design, and Product teams and help transform the future of healthcare. If you’re interested in joining us, explore opportunities at www.cadence.care.
*Note that in all Cadence videos posted on this page, testimonials are those of real Cadence patients who have not been compensated and voluntarily provided their statements and opinions. Patient results and experiences with Cadence may vary and are unique and individual to each patient.
- Industry Hospital & Health Care
- Website https://www.cadence.care/
- LinkedIn https://www.linkedin.com/company/cadencerpm/about/
Related People
Chris AltchekFounder
United States -
Santa Barbara, California
On a mission to help physicians bring more responsive, personalized, and data-driven care to patients in the comfort of their own homes.
Previously co-founder/ceo of Mic (www.mic.com) an impact-driven internet media company. Mic successfully changed government policies, reached monthly audience of over 100 million users, developed innovative monetization, and sold in 2018.
Before co-founding Mic in 2011, worked at Goldman Sachs, the White House, and Michael Bloomberg’s 2009 re-election campaign.
Crain’s 40 Under 40 in 2017, Forbes’ 30 Under 30 in 2014, and Goldman Sachs’ 100 Most Intriguing Entrepreneurs in 2015 and 2016.
Passionate about organizations that have broad social impact. Always learning & improving.
Coopah | $1,901,280 | (Nov 19, 2024)
Revisto | $4,000,000 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
ELICIT PLANT | $48,000,000 | (Nov 15, 2024)
Airbound | $1,700,000 | (Nov 15, 2024)
Influur | $10,000,000 | (Nov 15, 2024)
Naturbeads | $9,890,632 | (Nov 15, 2024)